The Cigna Group vs ELEVANCE HEALTH, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CI and ELV diverge most: on ev/ebitda, CI reads 7.9 and ELV reads 17.7; on return on invested capital, CI reads 11.1% and ELV reads 5.4%. The rest of the comparable metrics sit closer together. What ELV's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | CI | ELV |
|---|---|---|
| Price | $282.30 | $412.51 |
| Market cap | $74.5B | $89.9B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Mature |
| P/E | 11.7 | 18.3 |
| P/B | 1.74 | 2.00 |
| P/S | 0.26 | 0.45 |
| EV/EBITDA | 7.9 | 17.7 |
| Revenue growth | +7.8% | +6.5% |
| Operating margin | 3.7% | 3.5% |
| Net margin | 2.2% | 2.5% |
| Return on equity | 14.5% | 11.0% |
| Return on assets | 4.0% | 3.9% |
| Return on invested capital | 11.1% | 5.4% |
| FCF yield | 13.8% | 7.0% |
| Dividend yield | 2.1% | 1.4% |
| Debt / equity | 0.74 | 0.69 |
| Current ratio | 0.85 | 1.52 |
| Altman Z (solvency) | 2.63 | 2.92 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.